March 18, 2020
As ASTRO members grapple with major changes and disruptions due to COVID-19, ASTRO is advocating with federal agencies and payers for flexibility and support for radiation oncology clinics. In recent days, ASTRO has written CMS seeking:
In addition, ASTRO has asked the Centers for Disease Control and Prevention for COVID-19 specific guidance for radiation oncology practices. ASTRO also will soon urge private insurers and Medicare Advantage plans to suspend radiation therapy prior authorization requirements during the COVID-19 public health crisis. ASTRO members should contact the health policy team to notify us of policies that are impeding radiation oncologists from treating cancer patients and supporting COVID-19 response.